Consensus symposium on combined antiviral therapy; Overview of interferon and IL-2 combinations for the treatment of HIV infection

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 105-109

  Sneller, Michael C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Alpha interferon; Cytokine; HIV; Interleukin 2

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CD4 ANTIGEN; GAMMA INTERFERON; MACROGOL; ZIDOVUDINE;

ANTINEOPLASTIC ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG POTENTIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; INFLUENZA; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LIVER DYSFUNCTION; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0029918484     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00930-2     Document Type: Conference Paper

References (18)

1. Edlin, B.R., Weinstein, R.A., Whaling, S.M., Ou, C.Y., Connolly, P.J., Moore, J.L. and Bitran, J.D. (1992) Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction. J. Infect. Dis. 165, 793-798.
2. Fischl, M.A., Uttamchandani, R.B., Resnick, L., Agarwal, R., Fletcher, M.A., Patrone, R.J., Dearmas, L., Chidekel, J., McCann, M. and Myers, M. (1991) A phase I study of recombinant human interferon-alpha 2α or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. J. Acquir. Immune Defic. Synd. 4, 1-10.
3. Francis, M.L., Meltzer, M.S. and Gendelman, H.E. (1992) Interferons in the persistence, pathogenesis, and treatment of HIV infection. Aids Res. Hum. Retroviruses 8, 199-207.
4. Ho, D.D., Hartshorn, K.L., Rota, T.R., Andrews, C.A., Kaplan, J.C., Schooley, R.T. and Hirsch, M.S. (1985) Recombinant human interferon alfa - A suppresses HTLV-III replication in vitro. Lancet 1, 602-604.
5. Jonhson, V.A., Barlow, M.A., Merrill, D.P., Chou, T.C. and Hirsch, M.S. (1990) Three-drug syngergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-α. J. Infect. Dis. 161, 1059-1067.
6. Jos Frissen, P.H., van der Ende, M.E., C.H. T.N., Weigel, H.M., Schreij, G.S., Kauffmann, R.H., Koopmans, P.P., Hoepelman, A.I., de B.J.B., Weverling, G.J., Haverkamp, G., Dowd, P., Miedema, F., Schuurman, R., Boucher, C.A. and J.M., Lange. (1994) Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J. Infect. Dis. 169, 1351-1355.
7. Kovacs, J.A., Deyton, L., Davey, R., Falloon, J., Zunich, K., Lee, D., Metcalf, J.A., Bigley, J.W., Sawyer, L.A., Zoon, K.C., Masur, H., Fauci, A.S. and Lane, H.C. (1989) Combined zidovudine and interferon-α therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 111, 280-287.
8. Kovacs, J.A., Baseler, M., Dewar, R.J., Vogel, S., Davey, R.J., Falloon, J., Polis, M.A., Walker, R.E., Stevens, R., Salzman, N.P. et al. (1995) Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N. Engl. J. Med. 332, 567-975.
9. Lane, H.C., Davey, V., Kovacs, J.A., Feinberg, J., Metcalf, J.A., Herpin, B., Walker, R., Deyton, L., Davey, R.T. and Falloon, J. (1990) Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Ann. Intern. Med. 112, 805-811.
10. McMahon, D.K., Armstrong, J.A., Huang, X.L., Rinaldo, C.J., Gupta, P., Whiteside, T.L., Pazin, G.J., Tripoli, C. and Ho, M. (1994) A phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine. AIDS 8, 59-66.
11. Schwartz, D.H., Skowron, G. and Merigan, T.C. (1991) Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. J. Acquir. Immune Defic. Synd. 4, 11-23.
12. Shirazi, Y. and Pitha, P. (1992) Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. J. Virol. 66, 1321-1328.
13. Sneller, M.C. and Lane, H.C. (1993) Immunologic approaches to the therapy of HIV-1 infection. Ann. N.Y. Acad. Sci. 685, 687-696.
14. Teppler, H., Kaplan, G., Smith, K., Cameron, P., Montana, A., Meyn, P. and Cohn, Z. (1993a) Efficacy of low dosese of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 167, 291-298.
15. Teppler, H., Kaplan, G., Smith, K.A., Montana, A.L., Meyn, P. and Cohn, Z.A. (1993b) Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 177, 483-492.
16. Waites, L., Fyfe, G., Senechek, D. et al. (1992) Polyethylene glycol modified interleukin-2 (PEG IL-2) therapy in HIV seropositive individuals [abstract no. PuB 7580]. In: Program and abstracts: VIII International Conference on AIDS (Amsterdam). Congrex Holland BV.
17. Wood, R., Montoya, J.G., Kundu, S.K., Schwartz, D.H. and Merigan, T.C. (1993) Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study. J. Infect. Dis. 167, 519-525.
18. Yamada, O., Hattori, N., Kurimura, T., Kita, M. and Kishida, T. (1988) Inhibition of growth of HIV by human natural interferon in vitro. Aids Res. Hum. Retroviruses 4, 287-294.